• Media type: E-Article
  • Title: Proteins implicated in muscular dystrophy and cancer are functional constituents of the centrosome
  • Contributor: Winter, Lilli; Kustermann, Monika; Ernhofer, Büsra; Höger, Harald; Bittner, Reginald E; Schmidt, Wolfgang M
  • Published: Life Science Alliance, LLC, 2022
  • Published in: Life Science Alliance, 5 (2022) 11, Seite e202201367
  • Language: English
  • DOI: 10.26508/lsa.202201367
  • ISSN: 2575-1077
  • Origination:
  • Footnote:
  • Description: Aberrant expression of dystrophin, utrophin, dysferlin, or calpain-3 was originally identified in muscular dystrophies (MDs). Increasing evidence now indicates that these proteins might act as tumor suppressors in myogenic and non-myogenic cancers. As DNA damage and somatic aneuploidy, hallmarks of cancer, are early pathological signs in MDs, we hypothesized that a common pathway might involve the centrosome. Here, we show that dystrophin, utrophin, dysferlin, and calpain-3 are functional constituents of the centrosome. In myoblasts, lack of any of these proteins caused excess centrosomes, centrosome misorientation, nuclear abnormalities, and impaired microtubule nucleation. In dystrophin double-mutants, these defects were significantly aggravated. Moreover, we demonstrate that also in non-myogenic cells, all four MD-related proteins localize to the centrosome, including the muscle-specific full-length dystrophin isoform. Therefore, MD-related proteins might share a convergent function at the centrosome in addition to their diverse, well-established muscle-specific functions. Thus, our findings support the notion that cancer-like centrosome-related defects underlie MDs and establish a novel concept linking MDs to cancer.
  • Access State: Open Access